You are here

AstraZeneca

AstraZeneca diabetes drug combination faces delay after FDA rebuff

Yahoo/Reuters

Fri, 10/16/15 - 06:58 am

Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases

Forbes

Wed, 10/14/15 - 02:15 pm

Bristol-Myers Squibb

Teva Pharmaceutical

Now They're Chasing AstraZeneza: If Only These People Understood The System

Forbes

Wed, 10/14/15 - 09:52 am

These Big Pharma Companies Are in Need of an Acquisition

Motley Fool

Tue, 10/13/15 - 10:41 am

AstraZeneca halts a pair of lung cancer trials over a safety scare

Fierce Biotech

Fri, 10/9/15 - 10:03 am

clinical trials

Clovis Oncology Inc Giving AstraZeneca plc A Hard Time In Cancer

Bidness, ETC

Fri, 10/2/15 - 09:11 am

Clovis Oncology

non-small cell lung cancer

Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?

Motley Fool

Wed, 09/30/15 - 07:59 pm

cancer immunotherapy

Juno Therapeutics

Bristol-Myers Squibb

Racing AstraZeneca, Clovis gets a speedy FDA review for its lung cancer drug

Fierce Biotech

Wed, 09/30/15 - 04:43 pm

Clovis Oncology

Novo's weekly diabetes drug clears another Phase III hurdle

Fierce Biotech

Fri, 09/25/15 - 08:45 pm

op-selling drugs might be first in line for Medicare price negotiations

Fierce Pharma

Wed, 09/23/15 - 09:50 pm

Hillary Clinton

AstraZeneca embraces crowdsourcing in a mix-and-match cancer R&D contest

Fierce Biotech

Tue, 09/22/15 - 11:24 am

AstraZeneca forges partnership with BARDA to develop powerful antibiotics

BioPharma Dive

Fri, 09/18/15 - 11:21 am

Biotechs Coming Off One Of The Busiest Weeks In Recent Memory

Yahoo/Benzinga

Tue, 09/15/15 - 09:04 am

Gilead Sciences

Clovis Oncology

Bristol-Myers Squibb

Tetraphase Pharmaceuticals

The Medicare Gravy Train Into Big Pharma's Pockets Keeps Growing

Seeking Alpha

Mon, 09/14/15 - 10:57 am

Gilead Sciences

Isis-AstraZeneca Collaboration For Antisense Drugs Gets HSR Clearance

NASDAQ.com

Sat, 09/12/15 - 01:21 pm

Isis Pharmaceuticals

AstraZeneca picks up discarded Amgen plant as part of its biologics expansion

Fierce Pharma

Fri, 09/11/15 - 10:48 am

drug manufacturing

AZ's high-powered Crestor could gain from payer limits on PCSK9 meds

Fierce Pharma Marketing

Fri, 09/11/15 - 09:55 am

PCSK9 inhibitors

Clovis leaps as AstraZeneca's AZD9291 disappoints on lung cancer

Fierce Biotech

Thu, 09/10/15 - 05:54 pm

Clovis Oncology

non-small cell lung cancer

AstraZeneca nabs priority review voucher as Wellstat bags FDA OK

Fierce Biotech

Tue, 09/8/15 - 08:21 am

priority review

review vouchers

New data expected at lung-cancer conference on experimental drug combos

Medical Marketing and Media

Fri, 09/4/15 - 09:01 am

Bristol-Myers Squibb

Pages